Advertisement

Topics

Surmodics secures IDE approval to start trial of SurVeil drug-coated balloon

06:30 EDT 27 Jul 2017 | Medical Business Review

Surmodics has received an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to initiate a pivotal clinical trial of the SurVeilâ„¢ drug-coated balloon (DCB).

Original Article: Surmodics secures IDE approval to start trial of SurVeil drug-coated balloon

NEXT ARTICLE

More From BioPortfolio on "Surmodics secures IDE approval to start trial of SurVeil drug-coated balloon"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...